Insider Trading › MRVI › Insiders
MARAVAI LIFESCIENCES HOLDINGS, INC.
MRVI·Nasdaq·
United States·Insider activity
United States·Insider activity$7.85
-0.67 (-7.86%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
MRVI
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
MRVIS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, MRVI insiders filed 0 purchases ($0) and 2 sales ($254K) on the open market, by 1 insider. Newest filing Jun 10, 2026 (3 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by MRVI insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$254KSales · 180 days
19Open-market transactions on record
1Insiders filing · 180 days
Purchases (code P) and sales (code S) of MRVI common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
19 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| ORESHACK KURTGeneral Counsel | Sale | −25.0K | $5.10 | $127K | 335.8Kdirect | Jun 10, 2026 | Jun 10, 2026 | Form 4 ↗ |
| ORESHACK KURTGeneral Counsel | Sale | −25.0K | $5.06 | $126K | 360.8Kdirect | Jun 9, 2026 | Jun 10, 2026 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Purchase | +48.5K | $3.67 | $178K | 155.1Kdirect | Dec 8, 2025 | Dec 9, 2025 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Purchase | +51.5K | $3.70 | $190K | 106.6Kdirect | Dec 5, 2025 | Dec 9, 2025 | Form 4 ↗ |
| Brust BerndChief Executive Officer · Director | Purchase | +216.2K | $3.25 | $703K | 466.8Kindirect | Nov 13, 2025 | Nov 17, 2025 | Form 4 ↗ |
| Brust BerndChief Executive Officer · Director | Purchase | +93.4K | $3.21 | $300K | 250.6Kindirect | Nov 12, 2025 | Nov 13, 2025 | Form 4 ↗ |
| Brust BerndChief Executive Officer · Director | Purchase | +157.2K | $3.24 | $509K | 157.2Kindirect | Nov 11, 2025 | Nov 13, 2025 | Form 4 ↗ |
| ORESHACK KURTGeneral Counsel | Sale | −25.0K | $5.03 | $126K | 167.6Kdirect | Jan 31, 2025 | Jan 31, 2025 | Form 4 ↗ |
| DeFord John ADirector | Purchase | +17.5K | $5.75 | $101K | 70.0Kdirect | Nov 12, 2024 | Nov 14, 2024 | Form 4 ↗ |
| HULL CARLSee Remarks · Director | Purchase | +175.0K | $5.64 | $987K | 175.0Kindirect | Nov 11, 2024 | Nov 12, 2024 | Form 4 ↗ |
| MARAVAI LIFE SCIENCES HOLDINGS, LLCDirector · 10% owner | Sale | −9.9M | $9.82 | $97.6M | 20.2Mindirect | May 28, 2024 | May 30, 2024 | Form 4 ↗ |
| HULL CARLChief Executive Officer · Director | Purchase | +35.0K | $26.94 | $943K | 35.0Kindirect | Nov 25, 2020 | Nov 30, 2020 | Form 4 ↗ |
| GRAY SUSANNAHDirector | Purchase | +20.0K | $27.00 | $540K | 31.9Kdirect | Nov 24, 2020 | Nov 25, 2020 | Form 4 ↗ |
| SELLERS LISASee Remarks | Purchase | +18.9K | $27.00 | $510K | 18.9Kdirect | Nov 24, 2020 | Nov 25, 2020 | Form 4 ↗ |
| Hance Robert BDirector | Purchase | +10.0K | $27.00 | $270K | 21.9Kdirect | Nov 24, 2020 | Nov 25, 2020 | Form 4 ↗ |
| PRAHALAD MURALIDirector | Purchase | +18.0K | $27.00 | $486K | 29.9Kdirect | Nov 24, 2020 | Nov 25, 2020 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Purchase | +15.0K | $27.00 | $405K | 26.9Kdirect | Nov 24, 2020 | Nov 25, 2020 | Form 4 ↗ |
| Hopfield JessicaDirector | Purchase | +50.0K | $27.00 | $1.4M | 61.9Kdirect | Nov 24, 2020 | Nov 25, 2020 | Form 4 ↗ |
| ORESHACK KURTGeneral Counsel | Purchase | +7,500 | $27.00 | $203K | 7,500direct | Nov 24, 2020 | Nov 25, 2020 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →